F. Porto

Bisphosphonate treatment in ochronotic osteoporotic patients

M. Proietta, D. Pisani, G. Aliberti, 2007, Clinical Rheumatology.

Macrophage metalloprotease (MMP)-12 as a cardiovascular biomarker

L. Tritapepe, C. D. di Gioia, F. Del Porto, 2016 .

Inflammation and immune response in carotid artery stenosis

F. Del Porto, M. Proietta, M. Taurino, 2019, Italian Journal of Vascular and Endovascular Surgery.

The 677C → T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in epileptic patients affected by systemic lupus erythematosus

A. Amoroso, A. Francia, S. Galluzzo, 2002, Seizure.

Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis

F. Tinti, B. Laganà, I. Nofroni, 2007 .

Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.

I. Donatelli, L. Campitelli, R. Nisini, 2006, Vaccine.

Antithrombin III metabolism in the pulmonary vessel endothelium

L. Tritapepe, M. Proietta, G. Aliberti, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis.

M. Vitale, F. Tinti, B. Laganà, 2007, Rheumatology.

Nerve Growth Factor and Brain‐Derived Neurotrophic Factor Levels in Patients with Rheumatoid Arthritis Treated with TNF‐α Blockers

B. Laganà, L. Aloe, I. Nofroni, 2006 .